文献速递主动脉疾病

高容量中心腹主动脉瘤腔内修复与开放修复的成本效果分析

Cost-effectiveness analysis of endovascular versus open repair of abdominal aortic aneurysm in a high-volume center.
PubMed 文献 · J Vasc Surg · 2019-02-15

该研究基于2002至2015年单中心494例择期腹主动脉瘤修复患者,比较EVAR与开放修复。

要点

  • EVAR的3年每QALY成本中位数低于开放修复,具有成本效果优势。
  • EVAR围手术期并发症发生率显著低于开放修复。
  • 围手术期死亡率与再干预率在两种术式间无显著差异。

核心结论

  • 在高容量中心,EVAR与开放修复相比具有更好的成本效果,每QALY成本更低。

研究设计与样本

  • 单中心回顾性审计,纳入2002至2015年494例择期腹主动脉瘤修复患者,其中EVAR 401例、开放修复93例。
  • 主要终点为3年每QALY成本,QALY基于质量调整无症状或毒性时间评估。

主要发现

  • 亚组分析未发现术式与全因死亡率、QALY、成本或每QALY成本的改善存在关联。

临床怎么用

  • 在解剖适合的择期腹主动脉瘤患者中,EVAR可降低围手术期并发症并具有更优的成本效果。
  • 决策时需结合再干预风险与成本效果综合评估,尤其应参考本中心高容量经验。

局限性

  • 为单中心回顾性审计,非随机分组,可能存在选择偏倚。
  • 开放修复样本量较小(93例),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) is the standard treatment for anatomically suitable patients. EVAR has been associated with a lower perioperative morbidity and mortality compared with open surgical repair (OSR) at the expense of increased reinterventions and costs. We aimed to compare the outcomes of EVAR and OSR for elective AAA repair. The primary end point was cost per QALY at 3 years. Secondary end points were perioperative morbidity and mortality; freedom from reintervention; length of hospital, high-dependency unit, and intensive care unit stay; and freedom from all-cause mortality. METHODS: The project was approved by the Galway Clinical Research Ethics Committee. This project followed the Declaration of Helsinki. This was an audit of interventions that had already taken place. No active clinical intervention was undertaken, and patients' anonymity was preserved; thus, individual patient consent was not obtained. Data on all elective AAA repairs at a tertiary referral vascular center were collected from 2002 to 2015. Demographics and outcomes were reported according to the Society for Vascular Surgery guidelines. QALY was measured on the basis of a quality-adjusted time without symptoms or toxicity assessment. Data were analyzed using parametric and nonparametric tests. RESULTS: Between 2002 and 2015, a total of 494 patients required elective AAA surgery; 401 underwent EVAR and 93 underwent OSR. Demographics and vascular-related risk factors were similar in both groups. Median (interquartile range) cost per QALY at 3 years was €5776 (€5541-€6481) for EVAR vs €7101 (€5812-€8952) for OSR (P < .001). EVAR was associated with reduced perioperative morbidity (12.2% vs 50%; P < .001). There was no significant association between procedure and perioperative mortality (EVAR, 1.7%; OSR, 4.3%; P = .130). There was no significant association found between the procedure and reintervention (P = .502). Our subgroup analysis found no association between procedure and improvement in all-cause mortality, QALYs, costs, or cost per QALY. CONCLUSIONS: EVAR is cost-effective with improved cost per QALY compared with OSR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Canning P, Tawfick W, Whelan N, et al. Cost-effectiveness analysis of endovascular versus open repair of abdominal aortic aneurysm in a high-volume center. J Vasc Surg. 2019. PMID: 30777686. doi:10.1016/j.jvs.2018.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。